This article was written by Follow Fredrik Arnold is a former quality service analyst. He is now reporting investment ideas with a primary focus on dividend yields by utilizing free cash flow
Boston Scientific BSX (NYSE: BSX) reported its Q3 results last month, with revenues and earnings beating the street estimates. However, we believe BSX stock
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands